Role of global longitudinal strain diastolic index in assessment of patients with suspected obstructive coronary artery disease and normal or mildly reduced ejection fraction
Romanian Journal of Cardiology · 2020
DOI: 10.47803/rjc.2020.30.2.222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Cardiology, 2020. Verfasst von Mihaela Bolog und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Objective – To examine the utility of global longitudinal strain imaging diastolic index (SI-DI) in the assessment of patients with suspected obstructive coronary artery disease (CAD). Methods – We performed rest 2D standard echocardiography and strain imaging in 30 healthy subjects and in 148 patients with normal or mildly reduced ejection fraction and indication for coronarography for suspected obstructive CAD. Standard echocardiographic and strain parameters were analysed. Results – Global SI-DI was signifi cantly lower in the selected vs control group (p
Zitieren
APA
Bolog, M., Dumitrescu, M., Romanoschi, F., Pacuraru, E., & Rapa, A. (2020). Role of global longitudinal strain diastolic index in assessment of patients with suspected obstructive coronary artery disease and normal or mildly reduced ejection fraction. Romanian Journal of Cardiology. https://doi.org/10.47803/rjc.2020.30.2.222
Vancouver
Bolog M, Dumitrescu M, Romanoschi F, Pacuraru E, Rapa A. Role of global longitudinal strain diastolic index in assessment of patients with suspected obstructive coronary artery disease and normal or mildly reduced ejection fraction. Romanian Journal of Cardiology. 2020. doi:10.47803/rjc.2020.30.2.222
BibTeX
@article{Bolog2020,
author = {Bolog, Mihaela and Dumitrescu, Mihaela and Romanoschi, Florentina and Pacuraru, Elena and Rapa, Alina},
title = {Role of global longitudinal strain diastolic index in assessment of patients with suspected obstructive coronary artery disease and normal or mildly reduced ejection fraction},
journal = {Romanian Journal of Cardiology},
year = {2020},
doi = {10.47803/rjc.2020.30.2.222}
}
EUVIMED